A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease. OH&RM [Internett]. 29. september 2023 [sitert 11. juli 2026];4(4):19-26. Tilgjengelig på: https://ojs.maxaccs.ie/index.php/journal-ohrm-bba-md/article/view/374